DVAI34:BVMF
Davita Inc BDR
884,70Â R$
0,00%
(0,00) 1 p
7. okt, 16:56:00 GMT −3 · BRL
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse DVAI34 põhistatistika genereerimine…
Ava
906,30Â R$
Kõrge
906,30Â R$
Madal
884,70Â R$
Turu kapit.
11,28Â mld
Keskm. maht
7,00
Maht
2,00
52 näd kõrgeim
1Â 253,26Â R$
52 näd madalaim
546,63Â R$
Käibivad aktsiad
63,80Â mln
Töötajate arv
78Â tuh
Ava
906,30Â R$
Kõrge
906,30Â R$
Madal
884,70Â R$
Turu kapit.
11,28Â mld
Keskm. maht
7,00
Maht
2,00
52 näd kõrgeim
1Â 253,26Â R$
52 näd madalaim
546,63Â R$
Käibivad aktsiad
63,80Â mln
Töötajate arv
78Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Yahoo Finance
·
7 tunni eest
DaVita Inc. (DVA) Stock Forecasts
AD HOC NEWS
·
1 päeva eest
DaVita stock weighs Q2 earnings growth against reimbursement risk
Profiil
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
Teave üksuse Davita Inc BDR kohta
TegevjuhtJavier J. Rodriguez
Töötajad78 tuh
Asutatud1992
PeakontoridDenver, Colorado, Ameerika Ãœhendriigid
SektorHealth care provider
Veebisaitdavita.com